A systematic review of the effects of pharmacological agents on walking function in people with spinal cord injury.

Studies of spinalized animals indicate that some pharmacological agents may act on receptors in the spinal cord, helping to produce coordinated locomotor movement. Other drugs may help to ameliorate the neuropathological changes resulting from spinal cord injury (SCI), such as spasticity or demyelination, to improve walking. The purpose of this study was to systematically review the effects of pharmacological agents on gait in people with SCI. A keyword literature search of articles that evaluated the effects of drugs on walking after SCI was performed using the databases MEDLINE/PubMed, CINAHL, EMBASE, PsycINFO, and hand searching. Two reviewers independently evaluated each study, using the Physiotherapy Evidence Database (PEDro) tool for randomized clinical trials (RCTs), and the modified Downs & Black scale for all other studies. Results were tabulated and levels of evidence were assigned. Eleven studies met the inclusion criteria. One RCT provided Level 1 evidence that GM-1 ganglioside in combination with physical therapy improved motor scores, walking velocity, and distance better than placebo and physical therapy in persons with incomplete SCI. Multiple studies (levels of evidence 1-5) showed that clonidine and cyproheptadine may improve locomotor function and walking speed in severely impaired individuals with incomplete SCI. Gains in walking speed associated with GM-1, cyproheptadine, and clonidine are low compared to those seen with locomotor training. There was also Level 1 evidence that 4-aminopyridine and L-dopa were no better than placebo in helping to improve gait. Two Level 5 studies showed that baclofen had little to no effect on improving walking in persons with incomplete SCI. There is limited evidence that pharmacological agents tested so far would facilitate the recovery of walking after SCI. More studies are needed to better understand the effects of drugs combined with gait training on walking outcomes in people with SCI.

[1]  N. Black,et al.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. , 1998, Journal of epidemiology and community health.

[2]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[3]  H. Winn,et al.  Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up: Results of the third National Acute Spinal Cord Injury Randomized Controlled Trial , 1998 .

[4]  J. Commissiong.  The synthesis and metabolism of catecholamines in the spinal cord of the rat after acute and chronic transections , 1985, Brain Research.

[5]  P. Winchester,et al.  A Prediction Model for Determining Over Ground Walking Speed After Locomotor Training in Persons With Motor Incomplete Spinal Cord Injury , 2009, The journal of spinal cord medicine.

[6]  H. Barbeau,et al.  The effects of cyproheptadine on locomotion and on spasticity in patients with spinal cord injuries. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[7]  A. Hosman,et al.  Who wants to walk? Preferences for recovery after SCI: a longitudinal and cross-sectional study , 2008, Spinal Cord.

[8]  Benjamin E. Reubinoff,et al.  Neural progenitors from human embryonic stem cells , 2001, Nature Biotechnology.

[9]  S. Satya‐Murti.  Evidence-based Medicine: How to Practice and Teach EBM , 1997 .

[10]  V. Dietz,et al.  Effectiveness of automated locomotor training in patients with chronic incomplete spinal cord injury: a multicenter trial. , 2005, Archives of physical medicine and rehabilitation.

[11]  J. Iles,et al.  Presynaptic inhibition of monosynaptic reflexes in the lower limbs of subjects with upper motoneuron disease. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[12]  Igor A. Lavrov,et al.  Transformation of nonfunctional spinal circuits into functional states after the loss of brain input , 2009, Nature Neuroscience.

[13]  Xianjun Ren,et al.  Promoting axonal myelination for improving neurological recovery in spinal cord injury. , 2009, Journal of neurotrauma.

[14]  P. London.  Injury , 1969, Definitions.

[15]  M. Dimitrijevic,et al.  Evidence for a Spinal Central Pattern Generator in Humans a , 1998, Annals of the New York Academy of Sciences.

[16]  W. Rymer,et al.  Enhancement by serotonin of tonic vibration and stretch reflexes in the decerebrate cat , 1986, Experimental Brain Research.

[17]  W. Collins,et al.  Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. , 1992, Journal of neurosurgery.

[18]  J. Barthe,et al.  Serotonin‐induced activation of the network for locomotion in adult spinal rats , 1999, Journal of neuroscience research.

[19]  N. Andén,et al.  THE TIME COURSE OF THE DISAPPEARANCE OF NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE SPINAL CORD AFTER TRANSECTION. , 1964, Acta physiologica Scandinavica.

[20]  H. Bostock,et al.  Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres , 1980, Nature.

[21]  J. Segal,et al.  4-Aminopyridine alters gait characteristics and enhances locomotion in spinal cord injured humans. , 1998, The journal of spinal cord medicine.

[22]  Kevin D. Carlson,et al.  Impact of Experimental Design on Effect Size: Findings From the Research Literature on Training , 1999 .

[23]  L. Vinay,et al.  Serotonin refines the locomotor‐related alternations in the in vitro neonatal rat spinal cord , 2005, The European journal of neuroscience.

[24]  A. Hosman,et al.  Who wants to walk? Preferences for recovery after SCI: a longitudinal and cross-sectional study. , 2008 .

[25]  T. Brown.  The intrinsic factors in the act of progression in the mammal , 1911 .

[26]  A. Hicks,et al.  Spasticity after spinal cord injury , 2005, Spinal Cord.

[27]  Stephen G. Waxman,et al.  Demyelination in spinal cord injury , 1989, Journal of the Neurological Sciences.

[28]  S. Grillner,et al.  The effect of DOPA on the spinal cord. 7. Reflex activation of static gamma-motoneurones from the flexor reflex afferents. , 1967, Acta physiologica Scandinavica.

[29]  P. Jacobs,et al.  Involuntary stepping after chronic spinal cord injury. Evidence for a central rhythm generator for locomotion in man. , 1994, Brain : a journal of neurology.

[30]  Oswald Steward,et al.  Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury , 2005, The Journal of Neuroscience.

[31]  M. Lipsey,et al.  The efficacy of psychological, educational, and behavioral treatment. Confirmation from meta-analysis. , 1993, American Psychologist.

[32]  P. Guertin,et al.  Preliminary evidence of safety following administration of L-DOPA and buspirone in an incomplete monoplegic patient , 2009, Spinal Cord.

[33]  C. Blomstrand,et al.  Spinal Cord Injuries: Clinical, Functional, and Emotional Status , 1991 .

[34]  Catherine Sherrington,et al.  Evidence for physiotherapy practice: a survey of the Physiotherapy Evidence Database (PEDro). , 2002, The Australian journal of physiotherapy.

[35]  X. Li,et al.  Effects of baclofen on spinal reflexes and persistent inward currents in motoneurons of chronic spinal rats with spasticity. , 2004, Journal of neurophysiology.

[36]  S. Rossignol,et al.  Early locomotor training with clonidine in spinal cats. , 1998, Journal of neurophysiology.

[37]  M. Fehlings,et al.  A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. , 2011, Journal of neurotrauma.

[38]  M. Sparkes.  Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data , 1992 .

[39]  R. Nashmi,et al.  Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels , 2001, Brain Research Reviews.

[40]  A. Blight,et al.  The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial. , 1991, Journal of neurotrauma.

[41]  H. Barbeau,et al.  Modulation of Locomotor Patterns and Spasticity with Clonidine in Spinal Cord Injured Patients , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[42]  J. Vane,et al.  Tryptamines and spinal cord reflexes in cats. , 1967, British journal of pharmacology and chemotherapy.

[43]  S. Rossignol,et al.  Pharmacological aids to locomotor training after spinal injury in the cat , 2001, The Journal of physiology.

[44]  Effects of intrathecal alpha1- and alpha2-noradrenergic agonists and norepinephrine on locomotion in chronic spinal cats. , 1998, Journal of neurophysiology.

[45]  Serge Rossignol,et al.  Effects of Intrathecal α1- and α2-Noradrenergic Agonists and Norepinephrine on Locomotion in Chronic Spinal Cats , 1998 .

[46]  D. Brown,et al.  A global map for traumatic spinal cord injury epidemiology: towards a living data repository for injury prevention , 2011, Spinal Cord.

[47]  I. Estores,et al.  The consumer's perspective and the professional literature: what do persons with spinal cord injury want? , 2003, Journal of rehabilitation research and development.

[48]  R. Teasell,et al.  Stroke Rehabilitation Evidence-Based Review: Methodology , 2003, Topics in stroke rehabilitation.

[49]  K. Fouad,et al.  A systematic review of directly applied biologic therapies for acute spinal cord injury. , 2011, Journal of neurotrauma.

[50]  Roland R Roy,et al.  Spinal Cord-Transected Mice Learn to Step in Response to Quipazine Treatment and Robotic Training , 2005, The Journal of Neuroscience.

[51]  L. Noreau,et al.  Secondary Impairments After Spinal Cord Injury: A Population-Based Study , 2000, American journal of physical medicine & rehabilitation.

[52]  P. Trafton.  Spinal cord injuries. , 1982, The Surgical clinics of North America.

[53]  H. Barbeau,et al.  Effects of drugs on walking after spinal cord injury , 1998, Spinal Cord.

[54]  M. Fehlings,et al.  Emerging drugs for spinal cord injury , 2008, Expert opinion on emerging drugs.

[55]  M. Fehlings,et al.  A systematic review of cellular transplantation therapies for spinal cord injury. , 2011, Journal of neurotrauma.

[56]  R. Adone,et al.  Pharmacological interventions for spasticity following spinal cord injury. , 2000, The Cochrane database of systematic reviews.

[57]  B. Bussel,et al.  Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. , 1996, Archives of physical medicine and rehabilitation.

[58]  A. Lundberg,et al.  The effect of DOPA on the spinal cord. 2. A pharmacological analysis. , 1966, Acta physiologica Scandinavica.

[59]  J J Eng,et al.  Client-centred assessment and the identification of meaningful treatment goals for individuals with a spinal cord injury , 2004, Spinal Cord.

[60]  J. Guest,et al.  Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury , 2005, Experimental Neurology.

[61]  C. Polman,et al.  Randomized trial of 4-aminopyridine in patients with chronic incomplete spinal cord injury , 2001, Journal of Neurology.

[62]  Å. Seiger,et al.  The Stockholm Spinal Cord Injury Study: 2. Associations between clinical patient characteristics and post-acute medical problems , 1995, Paraplegia.

[63]  F. Geisler,et al.  The Sygen® Multicenter Acute Spinal Cord Injury Study , 2001, Spine.

[64]  F. Müller,et al.  Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study , 2001, The Lancet.

[65]  A. Lundberg,et al.  The effect of DOPA on the spinal cord. 6. Half-centre organization of interneurones transmitting effects from the flexor reflex afferents. , 1967, Acta physiologica Scandinavica.

[66]  S. Rossignol,et al.  Initiation and modulation of the locomotor pattern in the adult chronic spinal cat by noradrenergic, serotonergic and dopaminergic drugs , 1991, Brain Research.

[67]  J J Eng,et al.  A systematic review of functional ambulation outcome measures in spinal cord injury , 2008, Spinal Cord.

[68]  S. Grillner,et al.  On the central generation of locomotion in the low spinal cat , 1979, Experimental Brain Research.

[69]  A. Hicks,et al.  Treadmill training after spinal cord injury: it's not just about the walking. , 2008, Journal of rehabilitation research and development.

[70]  H. Barbeau,et al.  Effect of 4-aminopyridine on gait in ambulatory spinal cord injuries: a double-blind, placebo-controlled, crossover trial , 2004, Spinal Cord.

[71]  J. Fung,et al.  The combined effects of clonidine and cyproheptadine with interactive training on the modulation of locomotion in spinal cord injured subjects , 1990, Journal of the Neurological Sciences.

[72]  M. Gorassini,et al.  Role of endogenous release of norepinephrine in muscle spasms after chronic spinal cord injury. , 2007, Journal of neurophysiology.

[73]  K. Smith,et al.  Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension. , 2000, Brain : a journal of neurology.

[74]  Enrique Luis Graue Wiechers,et al.  Facts and Figures at a Glance , 2007 .

[75]  B. Bussel,et al.  Effects of intrathecal clonidine injection on spinal reflexes and human locomotion in incomplete paraplegic subjects , 1999, Experimental Brain Research.

[76]  H. Winn,et al.  Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. , 1998, Journal of neurosurgery.

[77]  P. Guertin,et al.  Oral administration of a tri‐therapy for central pattern generator activation in paraplegic mice: Proof‐of‐concept of efficacy , 2010, Biotechnology journal.

[78]  J. A. Gruner,et al.  Augmentation by 4-aminopyridine of vestibulospinal free fall responses in chronic spinal-injured cats , 1987, Journal of the Neurological Sciences.

[79]  K. Roach,et al.  Influence of a Locomotor Training Approach on Walking Speed and Distance in People With Chronic Spinal Cord Injury: A Randomized Clinical Trial , 2011, Physical Therapy.

[80]  A. Lundberg,et al.  The effect of DOPA on the spinal cord. 5. Reciprocal organization of pathways transmitting excitatory action to alpha motoneurones of flexors and extensors. , 1967, Acta physiologica Scandinavica.

[81]  J. Fawcett,et al.  Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures , 2007, Spinal Cord.

[82]  S. Rossignol,et al.  Recovery of locomotion after ventral and ventrolateral spinal lesions in the cat. II. Effects of noradrenergic and serotoninergic drugs. , 1999, Journal of neurophysiology.

[83]  Nerys Brick,et al.  Locomotor training for walking after spinal cord injury. , 2014, Orthopedic nursing.

[84]  M. Harris,et al.  GM-1 ganglioside administration combined with physical therapy restores ambulation in humans with chronic spinal cord injury , 1993, Neuroscience Letters.

[85]  Jaynie F. Yang,et al.  Changes in locomotor muscle activity after treadmill training in subjects with incomplete spinal cord injury. , 2009, Journal of neurophysiology.

[86]  S. Rossignol,et al.  Recovery of locomotion after ventral and ventrolateral spinal lesions in the cat. I. Deficits and adaptive mechanisms. , 1998, Journal of neurophysiology.

[87]  I. Mocchetti.  Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins , 2005, Cellular and Molecular Life Sciences CMLS.

[88]  J. Barthe,et al.  Locomotor recovery in the chronic spinal rat: effects of long‐term treatment with a 5‐HT2 agonist , 2002, The European journal of neuroscience.

[89]  V. Dietz,et al.  Levodopa therapy in incomplete spinal cord injury. , 2008, Journal of neurotrauma.

[90]  S. Rossignol,et al.  The effects of serotonergic drugs on the locomotor pattern and on cutaneous reflexes of the adult chronic spinal cat , 1990, Brain Research.

[91]  Andrei Krassioukov,et al.  The clinical problems in cardiovascular control following spinal cord injury: an overview. , 2006, Progress in brain research.

[92]  M. Carpenter,et al.  Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation , 2005, Glia.

[93]  A. Blight.  Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury , 1989, Brain Research Bulletin.

[94]  V. Edgerton,et al.  Robotic training and spinal cord plasticity , 2009, Brain Research Bulletin.

[95]  Hui Zhong,et al.  Step Training Reinforces Specific Spinal Locomotor Circuitry in Adult Spinal Rats , 2008, The Journal of Neuroscience.

[96]  S. Harkema.  Neural Plasticity after Human Spinal Cord Injury: Application of Locomotor Training to the Rehabilitation of Walking , 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[97]  Sherif M. Elbasiouny,et al.  Management of Spasticity After Spinal Cord Injury: Current Techniques and Future Directions , 2010, Neurorehabilitation and neural repair.

[98]  V. Belegu,et al.  Demyelination and remyelination after spinal cord injury. , 2006, Journal of neurotrauma.

[99]  K. Anderson.  Targeting recovery: priorities of the spinal cord-injured population. , 2004, Journal of neurotrauma.

[100]  S. Grillner,et al.  The locomotion of the acute spinal cat injected with clonidine i.v. , 1973, Brain research.

[101]  A. Carlsson,et al.  5-Hydroxytryptamine of the spinal cord normally and after transection , 1963, Experientia.